Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus
Keywords: لیپوپروتئین پلاسما; Type 2 diabetes mellitus (T2DM); Glimepiride; Blood glucose (BG); Plasma lipoprotein; Tissue plasminogen activator (t-PA); Plasminogen activator inhibitor type I (PAI-1)